These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 26721726

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Formulation and Evaluation of Anisamide-Targeted Amphiphilic Cyclodextrin Nanoparticles To Promote Therapeutic Gene Silencing in a 3D Prostate Cancer Bone Metastases Model.
    Evans JC, Malhotra M, Fitzgerald KA, Guo J, Cronin MF, Curtin CM, O'Brien FJ, Darcy R, O'Driscoll CM.
    Mol Pharm; 2017 Jan 03; 14(1):42-52. PubMed ID: 28043128
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X, Rahme K, Cong Z, Wang L, Zou Y, He Y, Yang H, Holmes JD, O'Driscoll CM, Guo J.
    Eur J Pharm Biopharm; 2019 Apr 03; 137():56-67. PubMed ID: 30779980
    [Abstract] [Full Text] [Related]

  • 5. Early-stage development of novel cyclodextrin-siRNA nanocomplexes allows for successful postnebulization transfection of bronchial epithelial cells.
    Hibbitts A, O'Mahony AM, Forde E, Nolan L, Ogier J, Desgranges S, Darcy R, MacLoughlin R, O'Driscoll CM, Cryan SA.
    J Aerosol Med Pulm Drug Deliv; 2014 Dec 03; 27(6):466-77. PubMed ID: 24665866
    [Abstract] [Full Text] [Related]

  • 6. Anisamide-targeted gold nanoparticles for siRNA delivery in prostate cancer - synthesis, physicochemical characterisation and in vitro evaluation.
    Fitzgerald KA, Rahme K, Guo J, Holmes JD, O'Driscoll CM.
    J Mater Chem B; 2016 Apr 07; 4(13):2242-2252. PubMed ID: 32263220
    [Abstract] [Full Text] [Related]

  • 7. Impact of anti-PLK1 siRNA-containing F3-targeted liposomes on the viability of both cancer and endothelial cells.
    Gomes-da-Silva LC, Ramalho JS, Pedroso de Lima MC, Simões S, Moreira JN.
    Eur J Pharm Biopharm; 2013 Nov 07; 85(3 Pt A):356-64. PubMed ID: 23659854
    [Abstract] [Full Text] [Related]

  • 8. Systemic delivery of siRNA with cationic lipid assisted PEG-PLA nanoparticles for cancer therapy.
    Yang XZ, Dou S, Sun TM, Mao CQ, Wang HX, Wang J.
    J Control Release; 2011 Dec 10; 156(2):203-11. PubMed ID: 21839126
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. ScFv-decorated PEG-PLA-based nanoparticles for enhanced siRNA delivery to Her2⁺ breast cancer.
    Dou S, Yang XZ, Xiong MH, Sun CY, Yao YD, Zhu YH, Wang J.
    Adv Healthc Mater; 2014 Nov 10; 3(11):1792-803. PubMed ID: 24947820
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD, Huang L.
    Mol Pharm; 2006 Nov 10; 3(5):579-88. PubMed ID: 17009857
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Folate-targeted amphiphilic cyclodextrin nanoparticles incorporating a fusogenic peptide deliver therapeutic siRNA and inhibit the invasive capacity of 3D prostate cancer tumours.
    Evans JC, Malhotra M, Sweeney K, Darcy R, Nelson CC, Hollier BG, O'Driscoll CM.
    Int J Pharm; 2017 Oct 30; 532(1):511-518. PubMed ID: 28916296
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glucose-linked sub-50-nm unimer polyion complex-assembled gold nanoparticles for targeted siRNA delivery to glucose transporter 1-overexpressing breast cancer stem-like cells.
    Yi Y, Kim HJ, Zheng M, Mi P, Naito M, Kim BS, Min HS, Hayashi K, Perche F, Toh K, Liu X, Mochida Y, Kinoh H, Cabral H, Miyata K, Kataoka K.
    J Control Release; 2019 Feb 10; 295():268-277. PubMed ID: 30639386
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and characterization of rabies virus glycoprotein-tagged amphiphilic cyclodextrins for siRNA delivery in human glioblastoma cells: in vitro analysis.
    Gooding M, Malhotra M, McCarthy DJ, Godinho BM, Cryan JF, Darcy R, O'Driscoll CM.
    Eur J Pharm Sci; 2015 Apr 25; 71():80-92. PubMed ID: 25703259
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Folate-targeted amphiphilic cyclodextrin.siRNA nanoparticles for prostate cancer therapy exhibit PSMA mediated uptake, therapeutic gene silencing in vitro and prolonged circulation in vivo.
    Evans JC, Malhotra M, Guo J, O'Shea JP, Hanrahan K, O'Neill A, Landry WD, Griffin BT, Darcy R, Watson RW, O'Driscoll CM.
    Nanomedicine; 2016 Nov 25; 12(8):2341-2351. PubMed ID: 27389146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.